PL3322721T3 - Nowe białka wiążące immunoglobulinę i ich zastosowanie w oczyszczaniu na bazie powinowactwa - Google Patents

Nowe białka wiążące immunoglobulinę i ich zastosowanie w oczyszczaniu na bazie powinowactwa

Info

Publication number
PL3322721T3
PL3322721T3 PL16742211T PL16742211T PL3322721T3 PL 3322721 T3 PL3322721 T3 PL 3322721T3 PL 16742211 T PL16742211 T PL 16742211T PL 16742211 T PL16742211 T PL 16742211T PL 3322721 T3 PL3322721 T3 PL 3322721T3
Authority
PL
Poland
Prior art keywords
binding proteins
affinity purification
novel immunoglobulin
immunoglobulin
novel
Prior art date
Application number
PL16742211T
Other languages
English (en)
Other versions
PL3322721T4 (pl
Inventor
Ulrich Haupts
Original Assignee
Navigo Proteins Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navigo Proteins Gmbh filed Critical Navigo Proteins Gmbh
Publication of PL3322721T3 publication Critical patent/PL3322721T3/pl
Publication of PL3322721T4 publication Critical patent/PL3322721T4/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
PL16742211T 2015-07-16 2016-07-14 Nowe białka wiążące immunoglobulinę i ich zastosowanie w oczyszczaniu na bazie powinowactwa PL3322721T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15177056 2015-07-16
EP16742211.2A EP3322721B1 (en) 2015-07-16 2016-07-14 Novel immunoglobulin-binding proteins and their use in affinity purification
PCT/EP2016/066774 WO2017009421A1 (en) 2015-07-16 2016-07-14 Novel immunoglobulin-binding proteins and their use in affinity purification

Publications (2)

Publication Number Publication Date
PL3322721T3 true PL3322721T3 (pl) 2022-06-06
PL3322721T4 PL3322721T4 (pl) 2022-06-06

Family

ID=53719659

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16742211T PL3322721T4 (pl) 2015-07-16 2016-07-14 Nowe białka wiążące immunoglobulinę i ich zastosowanie w oczyszczaniu na bazie powinowactwa

Country Status (14)

Country Link
US (1) US10808042B2 (pl)
EP (1) EP3322721B1 (pl)
JP (1) JP6856938B2 (pl)
KR (1) KR102064396B1 (pl)
CN (1) CN107922483B (pl)
AU (1) AU2016293063B2 (pl)
BR (1) BR112018000477A2 (pl)
CA (1) CA2991812C (pl)
DK (1) DK3322721T3 (pl)
ES (1) ES2916101T3 (pl)
IL (1) IL255196B2 (pl)
PL (1) PL3322721T4 (pl)
WO (1) WO2017009421A1 (pl)
ZA (1) ZA201801016B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3253785T3 (da) 2015-02-06 2019-07-08 Navigo Proteins Gmbh Hidtil ukendte egfr-bindingsproteiner
US10584152B2 (en) 2015-07-20 2020-03-10 Navigo Proteins Gmbh Binding proteins based on di-ubiquitin muteins and methods for generation
AU2017260274A1 (en) 2016-05-04 2018-11-01 Navigo Proteins Gmbh Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
KR101857953B1 (ko) 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
JP7181612B2 (ja) 2016-08-11 2022-12-01 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツング アルカリ安定性免疫グロブリン結合タンパク質
EP3521304B9 (en) * 2018-02-01 2023-10-04 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
EP3665189A1 (en) 2017-08-07 2020-06-17 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
EP3546476A1 (en) * 2018-03-26 2019-10-02 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
US11414466B2 (en) 2017-11-07 2022-08-16 Navigo Proteins Gmbh Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer
WO2020099442A1 (en) * 2018-11-12 2020-05-22 Navigo Proteins Gmbh Novel triple-helical polypeptides lacking binding affinity for the fc domain of immunoglobulin and uses thereof
EP3650465A1 (en) * 2018-11-12 2020-05-13 Navigo Proteins Gmbh Novel populations of polypeptides having a triple-helical structure
BR112021013026A2 (pt) * 2019-02-01 2021-10-13 Navigo Proteins Gmbh Proteínas de ligação à imunoglobulina, matriz de separação por afinidade, uso da proteína de ligação à imunoglobulina, e método de purificação por afinidade de uma proteína compreendendo uma sequência de imunoglobulina
CN112210013A (zh) 2019-07-03 2021-01-12 拜奥普罗塞亚科技有限责任公司 碱耐受性亲和色谱配体
KR20230038529A (ko) * 2020-07-15 2023-03-20 나피고 프로타인스 게엠베하 친화도 정제를 위한 면역글로불린 결합 단백질
WO2023285164A1 (en) * 2021-07-13 2023-01-19 Navigo Proteins Gmbh Affinity ligands for the purification and detection of ubiquitin muteins
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
CN114409801B (zh) * 2021-12-22 2023-04-18 苏州赛分科技股份有限公司 基于重组蛋白a的亲和层析介质及其制备方法和应用
GB202203478D0 (en) 2022-03-14 2022-04-27 Cytiva Bioprocess R & D Ab Vh3 binding polypeptides
CN117700501A (zh) * 2022-09-13 2024-03-15 普米斯生物技术(珠海)有限公司 免疫球蛋白结合蛋白及其应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873192A (en) 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
SE9103701D0 (sv) 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
AU7142796A (en) 1995-10-02 1997-04-28 Erasmus University Rotterdam Diagnosis method and reagents
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5789166A (en) 1995-12-08 1998-08-04 Stratagene Circular site-directed mutagenesis
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
FR2761689B1 (fr) 1997-04-02 1999-06-25 Transgene Sa Fibre adenovirale modifiee et adenovirus cibles
PT985032E (pt) 1997-05-28 2004-02-27 Discerna Ltd Complexos ribossomicos como particulas de seleccao para apresentacao in vitro e evolucao de proteinas
JP3614866B2 (ja) 1997-06-12 2005-01-26 リサーチ コーポレイション テクノロジーズ,インコーポレイティド 人工抗体ポリペプチド
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
TWI259837B (en) 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
US20030045681A1 (en) 1998-05-11 2003-03-06 Anthony J. Zelano Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
AU4243201A (en) 2000-02-24 2001-09-03 Eidgenoess Tech Hochschule Antibody specific for the ed-b domain of fibronectin, conjugates comprising saidantibody, and their use for the detection and treatment of angiogenesis
ES2373966T3 (es) 2000-02-24 2012-02-10 Philogen S.P.A. Composiciones y procedimientos para el tratamiento de la angiogénesis en lesiones patológicas.
US6799121B2 (en) 2000-03-30 2004-09-28 York University Sequencing of peptides by mass spectrometry
US20110179531A1 (en) 2000-05-09 2011-07-21 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20030073623A1 (en) 2001-07-30 2003-04-17 Drmanac Radoje T. Novel nucleic acid sequences obtained from various cDNA libraries
US20040043386A1 (en) 2002-08-30 2004-03-04 Todd Pray Methods and compositions for functional ubiquitin assays
ES2729974T3 (es) 2003-01-23 2019-11-07 Ono Pharmaceutical Co Anticuerpo específico de PD-1 y CD3 humanas
DE10324447A1 (de) 2003-05-28 2004-12-30 Scil Proteins Gmbh Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
GB2422836A (en) 2003-11-04 2006-08-09 Univ Yale Protein binding miniature proteins
US7393918B2 (en) 2003-12-11 2008-07-01 Yale University Protein binding miniature proteins and uses thereof
DE10360483B4 (de) 2003-12-22 2007-11-15 Scil Proteins Gmbh Expressionsvektor und dessen Verwendung
DE102004014983A1 (de) 2004-03-26 2005-10-20 Univ Stuttgart Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung
DE102004049479A1 (de) 2004-10-11 2006-04-13 Scil Proteins Gmbh Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie
AU2006246061A1 (en) 2005-05-11 2006-11-16 Philogen S.P.A. Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12
WO2007054120A1 (de) 2005-11-09 2007-05-18 Bayer Schering Pharma Aktiengesellschaft Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
EP1842553A1 (en) 2006-04-07 2007-10-10 Bayer Schering Pharma Aktiengesellschaft Combination of an anti-EDb fibronectin domain antibody/IL2 fusion protein and a further small molecule
AU2007247380B2 (en) 2006-05-08 2011-03-10 Philogen Spa Antibody-targeted cytokines for therapy
EP1892248A1 (en) 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
CN106422418B (zh) * 2006-09-29 2022-03-01 思拓凡生物工艺研发有限公司 用于抗体分离的包含来自金黄色葡萄球菌a蛋白的结构域c的层析配体
EP1925664A1 (en) 2006-11-15 2008-05-28 Scil proteins GmbH Artificial binding proteins based on a modified alpha helical region of ubiquitin
EP1955712A1 (en) 2007-02-09 2008-08-13 Scil proteins GmbH Multimeric conjugate
PL2310509T3 (pl) 2008-07-21 2015-08-31 Apogenix Ag Jednołańcuchowe cząsteczki TNFSF
ES2441803T3 (es) 2009-12-14 2014-02-06 Scil Proteins Gmbh Un método para identificar proteínas de ubicuitina heteromultímeras modificadas con capacidad para unirse a ligandos
JP5812303B2 (ja) * 2011-06-03 2015-11-11 国立研究開発法人産業技術総合研究所 酸性域での親和性が低下したプロテインa変異型タンパク質及び抗体捕捉剤
SG10201604559TA (en) * 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2012172055A1 (en) 2011-06-15 2012-12-20 Scil Proteins Gmbh Dimeric binding proteins based on modified ubiquitins
WO2012171541A1 (en) 2011-06-15 2012-12-20 Scil Proteins Gmbh Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins
US20150183846A1 (en) 2012-06-13 2015-07-02 Scil Proteins Gmbh Human fusion proteins comprising single chain tnfalpha and targeting domains
CN104640983A (zh) 2012-09-21 2015-05-20 株式会社钟化 亲和分离基质用蛋白质配体
EP2727942A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Bispecific antibodies against human EGFR, HER2, and HER3
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
WO2014094799A1 (en) 2012-12-19 2014-06-26 Scil-Proteins-Gmbh Ubiquitin moieties as a means for prolonging serum half-life
KR102236367B1 (ko) 2013-07-26 2021-04-05 삼성전자주식회사 DARPin을 포함하는 이중 특이 키메라 단백질
US20180030140A1 (en) 2015-02-06 2018-02-01 Navigo Proteins Gmbh Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragments
DK3253785T3 (da) 2015-02-06 2019-07-08 Navigo Proteins Gmbh Hidtil ukendte egfr-bindingsproteiner
AU2016295024B2 (en) 2015-07-20 2018-12-20 Navigo Proteins Gmbh Her2 binding proteins based on di-ubiquitin muteins
US10584152B2 (en) 2015-07-20 2020-03-10 Navigo Proteins Gmbh Binding proteins based on di-ubiquitin muteins and methods for generation
AU2017260274A1 (en) 2016-05-04 2018-11-01 Navigo Proteins Gmbh Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
JP7181612B2 (ja) 2016-08-11 2022-12-01 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツング アルカリ安定性免疫グロブリン結合タンパク質

Also Published As

Publication number Publication date
IL255196B (en) 2022-10-01
EP3322721B1 (en) 2021-12-08
CA2991812C (en) 2024-02-13
WO2017009421A1 (en) 2017-01-19
AU2016293063B2 (en) 2018-11-08
CA2991812A1 (en) 2017-01-19
JP2018523994A (ja) 2018-08-30
EP3322721A1 (en) 2018-05-23
ZA201801016B (en) 2019-07-31
BR112018000477A2 (pt) 2018-09-18
ES2916101T3 (es) 2022-06-28
PL3322721T4 (pl) 2022-06-06
CN107922483A (zh) 2018-04-17
KR20180031012A (ko) 2018-03-27
JP6856938B2 (ja) 2021-04-14
KR102064396B1 (ko) 2020-01-09
IL255196A0 (en) 2017-12-31
CN107922483B (zh) 2021-07-30
US10808042B2 (en) 2020-10-20
IL255196B2 (en) 2023-02-01
DK3322721T3 (da) 2022-03-14
US20180305463A1 (en) 2018-10-25

Similar Documents

Publication Publication Date Title
ZA201801016B (en) Novel immunoglobulin-binding proteins and their use in affinity purification
AU2016293063A1 (en) Novel immunoglobulin-binding proteins and their use in affinity purification
IL276106A (en) Garp-binding proteins and their uses
IL249327A0 (en) mic-1 fusion proteins and their uses
IL265489B (en) Recombinant binding proteins and their uses
PL3235830T3 (pl) Kompleks białkowy interleukiny 15 i jego zastosowanie
FI3909972T3 (fi) Pd1-cd28-fuusioproteiineja ja niiden käyttö lääkkeessä
HK1245293A1 (zh) 新的對綠膿菌熒光素和綠膿菌螯鐵蛋白特異性的蛋白質
SG11201505198WA (en) Protein purification methods
IL261040B (en) Protein purification
ZA201807140B (en) Fusion protein comprising ccl3 variant and use thereof cross-reference to related applications
GB201502950D0 (en) Improvements in crystallisation and small volume protein purification
GB201617925D0 (en) Proteins and uses
PT2991505T (pt) Enriquecimento de proteína